The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–284 of 284
Moon, H.-J., Finney, J., Xu, L., Moore, D., Welch, D. R., & Mure, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.502310 · Cited by 91
Jeftic, I. D., Jovicic, N. U., Pantic, J. M., Arsenijević, N., Lukić, M. L., & Pejnovic, N. N. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00178 · Cited by 90
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
Hirsova, P., Ibrahim, S. H., Bronk, S. F., Yagita∥, H., & Gores, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070599 · Cited by 90
MAREK, C. J., TUCKER, S. J., KONSTANTINOU, D. K., ELRICK, L. J., HAEFNER, D., SIGALAS, C., MURRAY, G. I., GOODWIN, B., & WRIGHT, M. C. (2005) · Biochemical Journal · doi:10.1042/bj20041598 · Cited by 89
Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
Moles, A., Tarrats, N., Morales, A., Domínguez, M., Bataller, R. A., Caballería, J., García‐Ruiz, C., Fernández-Checa, J. C., & Marı́, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091257 · Cited by 89
Li, C., Li, L., Lian, J., Watts, R., Nelson, R., Goodwin, B. J., & Lehner, R. S. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304584 · Cited by 87
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., & Cassader, M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101107.134820 · Cited by 87
Self-citationKim, K., Pyo, S., & Um, S. H. (2011) · Hepatology · doi:10.1002/hep.25537 · Cited by 86
An Overview of Hedgehog Signaling in Fibrosis
Hu, L., Lin, X., Lu, H., Chen, B., & Bai, Y. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095141 · Cited by 86
Ganji, S. H., Kukes, G. D., Lambrecht, N. W. G., Kashyap, M. L., & Kamanna, V. S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00181.2013 · Cited by 85
Role of S6K1 in regulation of SREBP1c expression in the liver
Li, S., Ogawa, W., Emi, A., Hayashi, K., Senga, Y., Nomura, K., Hara, K., Yu, D., & Kasuga, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.038 · Cited by 84
Saroglitazar for the treatment of dyslipidemia in diabetic patients
Joshi, S. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1009894 · Cited by 83
Li, L., Li, H., Garzel, B., Yang, H., Sueyoshi, T., Li, Q., Shu, Y., Zhang, J., Hu, B., Heyward, S. A., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097287 · Cited by 83
Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies
Theodore, M., McIntosh, D., Walters, T. S., Flores, A., Goodwin, J. S., & Arinze, I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437392 · Cited by 83
Stiuso, P., Scognamiglio, I., Murolo, M., Ferranti, P., Simone, C. D., Rizzo, M. R., Tuccillo, C., Caraglia, M., Loguercio, C., & Federico, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/169216 · Cited by 83
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction
Qin, C. X., Yang, Y. H., May, L. T., Gao, X., Stewart, A. G., Tu, Y., Woodman, O. L., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.012 · Cited by 81
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
Orr, S. K., Colas, R. A., Dalli, J., Chiang, N., & Serhan, C. N. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00370.2014 · Cited by 81
Titos, E., Clària, J., Planagumà, A., López‐Parra, M., Villamor, N., Párrizas, M., Carrió, A., Miquel, R., Jiménez, W., Arroyo, V., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1157fje · Cited by 80
Ai, D., Jiang, H., Westerterp, M., Murphy, A. J., Wang, M., Ganda, A., Abramowicz, S., Welch, C. L., Almazan, F., Zhu, Y., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.302313 · Cited by 79
Wehr, A., Baeck, C., Ulmer, T. F., Gaßler, N., Hittatiya, K., Luedde, T., Neumann, U. P., Trautwein, C., & Tacke, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112327 · Cited by 78
Iacobini, C., Menini, S., Ricci, P. C., Scipioni, A., Sansoni, V., Mazzitelli, G., Cordone, S., Pesce, C. M., Pugliese, F. R., Pricci, F., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2536 · Cited by 76
Pérez‐Martínez, L., Pérez‐Matute, P., Aguilera‐Lizarraga, J., Rubio-Mediavilla, S., Narro-Íñiguez, J., Recio, E., Ochoa‐Callejero, L., Oteo, J. A., & Blanco, J. R. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku071 · Cited by 76
Bojic, L. A., Telford, D. E., Fullerton, M. D., Ford, R. J., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Gros, R., Kemp, B. E., Steinberg, G. R., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046037 · Cited by 75
Torok, N. J., Dranoff, J. A., Schuppan, D., & Friedman, S. L. (2015) · Hepatology · doi:10.1002/hep.27720 · Cited by 74
Yin, J.-J., Gu, L., Wang, Y., Fan, N., Ma, Y., & Peng, Y. (2015) · Mediators of Inflammation · doi:10.1155/2015/272313 · Cited by 74
Toki, Y., Takenouchi, T., Harada, H., Tanuma, S., Kitani, H., Kojima, S., & Tsukimoto, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.011 · Cited by 74
Jung, T. W., Hwang, H., Hong, H. C., Choi, H. Y., Yoo, H. J., Baik, S. H., & Choi, K. M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.04.012 · Cited by 74
Wang, C., Cui, Y., Li, C., Zhang, Y., Xu, S. Z., Li, X., Li, H., & Zhang, X. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-165 · Cited by 72
Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity
Guy, C. D., Suzuki, A., Abdelmalek, M. F., Burchette, J. L., Diehl, A. M., & CRN, F. T. N. (2015) · Hepatology · doi:10.1002/hep.27235 · Cited by 72
Velkov, T. (2013) · PPAR Research · doi:10.1155/2013/938401 · Cited by 71
Musso, G., Cassader, M., Bo, S., Michieli, F. D., & Gambino, R. (2012) · Diabetes · doi:10.2337/db12-0858 · Cited by 70
Self-citationA tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor
Li, G., Lin, W., Araya, J. J., Chen, T., Timmermann, B. N., & Guo, G. L. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.11.006 · Cited by 69
Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
Lin, H. Y., Chang, K., Hung, C., Kuo, C., Hwang, S., Chen, H., Hung, C., & Lin, S. (2014) · BMC Immunology · doi:10.1186/s12865-014-0037-0 · Cited by 69
L., K., Liu, J., Wang, C.-X., Ni, J., Zhang, Y., Wu, Y.-F., Lv, L., Ruan, X. Z., & Liu, B. C. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt203 · Cited by 65
Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 63
Kang, Q., & Chen, A. (2009) · Endocrinology · doi:10.1210/en.2009-0517 · Cited by 63
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Castaño, D., Larequi, E., Belza, I., Astudillo, A. M., Martínez‐Ansó, E., Balsinde, J., Argemí, J., Aragón, T., Moreno-Aliaga, M. J., Muntané, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.012 · Cited by 62
Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
Li, Z., Ou-Yang, P.-H., & Han, X.-P. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.018 · Cited by 62
Biswas, A., Pasquel, D., Tyagi, R. K., & Mani, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.048 · Cited by 61
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
Hsieh, W.-C., MacKinnon, A. C., Lu, W., Jung, J., Boulter, L., Henderson, N. C., Simpson, K. J., Schotanus, B. A., Wojtacha, D., Bird, T. G., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306290 · Cited by 60
Roda, A., Pellicciari, R., Gioiello, A., Neri, F., Camborata, C., Passeri, D., Franco, F., Spinozzi, S., Colliva, C., Adorini, L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214650 · Cited by 59
Grammatikos, G., Mühle, C., Ferreirós, N., Schroeter, S., Bogdanou, D., Schwalm, S. A., Hintereder, G., Kornhuber, J., Zeuzem, S., Sarrazin, C., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.04.007 · Cited by 58
Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes
Sun, M., Cui, W., Woody, S. K., & Staudinger, J. L. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062307 · Cited by 58
Trentin, P. G., Ferreira, T. P. T., Arantes, A., Ciambarella, B. T., Cordeiro, R. S. B., Flower, R. J., Perretti, M., Martins, M. A., & Silva, P. M. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13109 · Cited by 57
Bruce, C. R., Risis, S., Babb, J. R., Yang, C., Lee, R. S., Henstridge, D. C., & Febbraio, M. A. (2012) · Endocrinology · doi:10.1210/en.2012-1847 · Cited by 57
Mogilenko, D. A., Кудрявцев, И. В., Shavva, V. S., Dizhe, E. B., Виленская, Е. Г., Efremov, A. M., Ap, P., & Orlov, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437525 · Cited by 55
Zhai, X., Qiao, H., Guan, W., Li, Z., Cheng, Y., Jia, X., & Zhou, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.055 · Cited by 55
Liu, J., Ma, K. L., Zhang, Y., Wu, Y., Hu, Z. B., Lv, L. L., Tang, R. N., Liu, H., Ruan, X. Z., & Liu, B. C. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.011 · Cited by 53
Choi, S. S., Witek, R. P., Yang, L., Omenetti, A., Syn, W., Moylan, C. A., Jung, Y., Karaca, G., Teaberry, V. S., Pereira, T. A., et al. (2010) · Hepatology · doi:10.1002/hep.23649 · Cited by 53
Xiao, Z., Ko, H. L., Goh, E. H., Wang, B., & Ren, E. C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt085 · Cited by 53
Wang, K., Damjanov, I., & Wan, Y. Y. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.129 · Cited by 52
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Carotti, A., Marinozzi, M., Custodi, C., Cerra, B., Pellicciari, R., Gioiello, A., & Macchiarulo, A. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666141112094058 · Cited by 51
Ding, L., Pang, S., Sun, Y., Tian, Y., Li, Y., & Dang, N. (2014) · International Journal of Endocrinology · doi:10.1155/2014/751859 · Cited by 50
Wang, C., Hu, L. T., Zhao, L., Yang, P., Moorhead, J. F., Varghese, Z., Chen, Y., & Ruan, X. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103071 · Cited by 49
Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injury
Volarević, V., Marković, B. S., Bojić, S., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444849 · Cited by 47
Increased Adiposity in Annexin A1-Deficient Mice
Akasheh, R. T., Pini, M., Pang, J., & Fantuzzi, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082608 · Cited by 47
Xing, X., Li, D., Chen, D., Zhou, L., Chonan, R., Yamahara, J., Wang, J., & Li, Y. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.001 · Cited by 46
Toriumi, K., Horikoshi, Y., OSAMURA, R. Y., Yamamoto, Y., Nakamura, N., & Takekoshi, S. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.145 · Cited by 46
Isakov, E., Weisman-Shomer, P., & Benhar, M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.07.012 · Cited by 46
Attenuation of plasma annexin A1 in human obesity
Kosicka, A., Cunliffe, A., Mackenzie, R., Zariwala, M. G., Perretti, M., Flower, R. J., & Renshaw, D. W. (2012) · The FASEB Journal · doi:10.1096/fj.12-213728 · Cited by 45
Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
Kumar, V., Mundra, V., & Mahato, R. I. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1239-5 · Cited by 45
Hoekstra, M., Lammers, B., Out, R., Li, Z., Eck, M. V., & van Berkel, T. J. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800131d · Cited by 44
Surapaneni, K. M., Priya, V. V., & Mallika, J. (2014) · PubMed · Cited by 44
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs)
Kornhuber, J., Tripal, P., Gulbins, E., & Muehlbacher, M. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1368-4_9 · Cited by 43
Targeting pro-resolution pathways to combat chronic inflammation in COPD.
Bozinovski, S., Anthony, D., & Vlahos, R. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.08.08 · Cited by 41
Baselga-Escudero, L., Bladé, C., Ribas-Latre, A., Casanova, E., Salvadó, M., Arola, L., & Arola-Arnal, A. (2014) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.014 · Cited by 40
Lee, D. V., Li, D., Yan, Q., Zhu, Y., Goodwin, B. J., Calle, R. A., Brenner, M. B., & Talukdar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111767 · Cited by 39
Cooper, D. L., Murrell, D. E., Roane, D. S., & Harirforoosh, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.024 · Cited by 33
Farooq, A., Hoque, R., Ouyang, X., Farooq, K. A., Ghani, A., Ahsan, M. K., Guerra, M. T., & Mehal, W. Z. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00073.2014 · Cited by 32
Liu, Y., Sen, S. R., Wannaiampikul, S., Palanivel, R., Hoo, R. L. C., Isserlin, R., Bader, G. D., Tungtrongchitr, R., Deshaies, Y., Xu, A., et al. (2015) · Biochemical Journal · doi:10.1042/bj20141455 · Cited by 27
Discontinued in 2013: diabetic drugs
Hedrington, M. S., & Davis, S. N. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.964859 · Cited by 26
Lim, H., Park, J., Lee, S., Choi, H., Lee, K., & Park, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.002 · Cited by 24
Lee, S. J., Kang, J. H., Choi, S. Y., Suk, K. T., Kim, D. J., & Kwon, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055979 · Cited by 23
Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin
Torricelli, C., Daveri, E., Salvadori, S., Valacchi, G., Ietta, F., Muscettola, M., Carlucci, F., & Maioli, E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.040 · Cited by 20
Talal, A. H., Feron-Rigodon, M., Madere, J., Subramanian, G. M., & Bornstein, J. D. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)61319-7 · Cited by 20
Ye, X., Qi, J., Ren, G., Xu, P., Wu, Y., Zhu, S., Yu, D., Li, S., Wu, Q., Muhi, R. L., et al. (2015) · Endocrine · doi:10.1007/s12020-014-0503-8 · Cited by 19
Lee, K., Kim, M., Lee, B., Goo, J., Kim, J., Naik, R., Seo, J. H., Kim, M. O., Byun, Y., Song, G., et al. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27114a · Cited by 13
Kim, M. O., Lee, S., Choi, K., Lee, S., Kim, H., Kang, H., Choi, M., Kwon, E. B., Kang, M. J., Kim, S., et al. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00447 · Cited by 13
[Information obtained by liver biopsy in 100 tuberculous patients].
Morère, P., Nouvet, G., Jp, S., Paillot, B., Métayer, J., & Hémet, J. (1975) · PubMed · Cited by 13
Roles of Oxidized Diacylglycerol for Carbon Tetrachloride-induced Liver Injury and Fibrosis in Mouse
Takekoshi, S., Kitatani, K., & Yamamoto, Y. (2014) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.14030 · Cited by 12
Xin, X.-M., Zhong, M.-X., Yang, G.-L., Peng, Y., Zhang, Y.-L., & Zhu, W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15727 · Cited by 12
Czaja, M. J. (2015) · Hepatology · doi:10.1002/hep.27858 · Cited by 10
Musso, G. (2015) · Hepatology · doi:10.1002/hep.27772 · Cited by 9
Self-citationZhang, J., Zhang, L., Chen, D., Fu, Y., Zhang, F., Yang, L., Xia, C.-M., Jiang, H., Tang, C., Xie, Z., et al. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.149 · Cited by 7
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Recent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Metformin and Its Benefits for Various Diseases
Lv, Z., & Guo, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00191 · Cited by 535
Arroyave-Ospina, J. C., Wu, Z., Geng, Y., & Moshage, H. (2021) · Antioxidants · doi:10.3390/antiox10020174 · Cited by 527
Metadata
- Authors
- Musso, G., Cassader, M., & Gambino, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-01-22
- Volume
- 15
- Issue
- 4
- Pages
- 249-274
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2273379630
- Cited by
- 412
- References
- 284
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.